Literature DB >> 16239508

Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.

Roman A Lukaszewski1, Dermot J Kenny, Rosa Taylor, D G Cerys Rees, M Gill Hartley, Petra C F Oyston.   

Abstract

The pathogenesis of infection with Yersinia pestis, the causative agent of plague, was examined following subcutaneous infection of BALB/c mice with a fully virulent strain expressing green fluorescent protein. Plate culturing, flow cytometry, and laser confocal microscopy of spleen homogenates throughout infection revealed three discernible stages of infection. The early phase was characterized by the presence of a small number of intracellular bacteria mostly within CD11b+ macrophages and Ly-6G+ neutrophils. These bacteria were not viable, as determined by plate culturing of spleen homogenates, until day 2 postinfection. Between days 2 and 4 postinfection, a plateau phase was observed, with bacterial burdens of 10(3) to 10(4) CFU per spleen. Flow cytometric analysis revealed that there was even distribution of Y. pestis within both CD11b+ macrophage and Ly-6G+ neutrophil populations on day 2 postinfection. However, from day 3 postinfection onward, intracellular bacteria were observed exclusively within splenic CD11b+ macrophages. The late phase of infection, between days 4 and 5 postinfection, was characterized by a rapid increase in bacterial numbers, as well as escape of bacteria into the extracellular compartment. Annexin V staining of spleens indicated that a large proportion of splenic neutrophils underwent rapid apoptosis on days 1 and 2 postinfection. Fewer macrophages underwent apoptosis during the same period. Our data suggest that during the early stages of Y. pestis infection, splenic neutrophils are responsible for limiting the growth of Y. pestis and that splenic macrophages provide safe intracellular shelters within which Y. pestis is able to grow and escape during the later stages of infection. This macrophage compliance can be overcome in vitro by stimulation with a combination of gamma interferon and tumor necrosis factor alpha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239508      PMCID: PMC1273833          DOI: 10.1128/IAI.73.11.7142-7150.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.

Authors:  S J Elvin; E D Williamson
Journal:  Microb Pathog       Date:  2000-10       Impact factor: 3.738

2.  Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.

Authors:  Andreas Sing; Andreas Roggenkamp; Anna M Geiger; Jürgen Heesemann
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

Authors:  J C Stephens; D E Reich; D B Goldstein; H D Shin; M W Smith; M Carrington; C Winkler; G A Huttley; R Allikmets; L Schriml; B Gerrard; M Malasky; M D Ramos; S Morlot; M Tzetis; C Oddoux; F S di Giovine; G Nasioulas; D Chandler; M Aseev; M Hanson; L Kalaydjieva; D Glavac; P Gasparini; E Kanavakis; M Claustres; M Kambouris; H Ostrer; G Duff; V Baranov; H Sibul; A Metspalu; D Goldman; N Martin; D Duffy; J Schmidtke; X Estivill; S J O'Brien; M Dean
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 4.  The Yersinia deadly kiss.

Authors:  G R Cornelis
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

5.  Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection.

Authors:  A Boland; G R Cornelis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.

Authors:  E D Williamson; P M Vesey; K J Gillhespy; S M Eley; M Green; R W Titball
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

7.  Immunohistochemical detection of Yersinia pestis in formalin-fixed, paraffin-embedded tissue.

Authors:  Jeannette Guarner; Wun-Ju Shieh; Patricia W Greer; Jean-Marc Gabastou; May Chu; Edward Hayes; Kurt B Nolte; Sherif R Zaki
Journal:  Am J Clin Pathol       Date:  2002-02       Impact factor: 2.493

8.  Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

Authors:  R Nakajima; R R Brubaker
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica.

Authors:  E Bohn; J Heesemann; S Ehlers; I B Autenrieth
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice.

Authors:  D M Monack; J Mecsas; D Bouley; S Falkow
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  81 in total

1.  Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.

Authors:  Christina J van Lier; Jian Sha; Michelle L Kirtley; Anthony Cao; Bethany L Tiner; Tatiana E Erova; Yingzi Cong; Elena V Kozlova; Vsevolod L Popov; Wallace B Baze; Ashok K Chopra
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of Yersinia pestis in macrophages.

Authors:  Jens P Grabenstein; Hana S Fukuto; Lance E Palmer; James B Bliska
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

Review 4.  Molecular Darwinian evolution of virulence in Yersinia pestis.

Authors:  Dongsheng Zhou; Ruifu Yang
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

5.  The resistance of BALB/cJ mice to Yersinia pestis maps to the major histocompatibility complex of chromosome 17.

Authors:  Joshua K Turner; Milton M McAllister; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

6.  Comparative Analyses of Transcriptional Profiles in Mouse Organs Using a Pneumonic Plague Model after Infection with Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant.

Authors:  Cristi L Galindo; Scott T Moen; Elena V Kozlova; Jian Sha; Harold R Garner; Stacy L Agar; Ashok K Chopra
Journal:  Comp Funct Genomics       Date:  2010-01-20

7.  Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification.

Authors:  Céline Pujol; Kathryn A Klein; Galina A Romanov; Lance E Palmer; Carol Cirota; Zijiang Zhao; James B Bliska
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

8.  Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis.

Authors:  Deyan Luo; Jr-Shiuan Lin; Michelle A Parent; Isis Mullarky-Kanevsky; Frank M Szaba; Lawrence W Kummer; Debra K Duso; Michael Tighe; Jim Hill; Andras Gruber; Nigel Mackman; David Gailani; Stephen T Smiley
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

9.  Yersinia pestis two-component gene regulatory systems promote survival in human neutrophils.

Authors:  Jason L O'Loughlin; Justin L Spinner; Scott A Minnich; Scott D Kobayashi
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

10.  Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.

Authors:  Ayelet Zauberman; Avital Tidhar; Yinon Levy; Erez Bar-Haim; Gideon Halperin; Yehuda Flashner; Sara Cohen; Avigdor Shafferman; Emanuelle Mamroud
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.